RIBOCICLIB

RIBOCICLIB was reported 32716 times

RIBOCICLIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER 205 0.6175
1 ELLIPTOCYTOSIS 45 0.5000
2 ROULEAUX FORMATION 25 0.4310
3 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 55 0.4135
4 HER2 NEGATIVE BREAST CANCER 21 0.4118
5 CARBOHYDRATE ANTIGEN 15-3 INCREASED 242 0.3180
6 PIK3CA-ACTIVATED MUTATION 89 0.2681
7 TUMOUR MARKER DECREASED 45 0.2514
8 TUMOUR MARKER ABNORMAL 57 0.1722
9 METASTASES TO BREAST 57 0.1717
10 POIKILOCYTOSIS 44 0.1588
11 BREAST CANCER METASTATIC 1678 0.1561
12 METASTASES TO THORAX 39 0.1542
13 METASTASES TO NECK 40 0.1434
14 METASTASES TO PELVIS 86 0.1361
15 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 62 0.1235
16 ANISOCYTOSIS 81 0.1233
17 HORMONE RECEPTOR POSITIVE BREAST CANCER 33 0.1213
18 ELECTROCARDIOGRAM PR SHORTENED 25 0.1190
19 BASOPHIL PERCENTAGE INCREASED 20 0.1143
20 METASTASES TO BONE 1825 0.1111
21 DECREASED IMMUNE RESPONSIVENESS 1057 0.1076
22 METASTASES TO SPINE 357 0.1061
23 BONE MARROW INFILTRATION 41 0.1059
24 METASTASES TO PLEURA 109 0.1039
25 METASTASES TO OVARY 31 0.0972
26 INVASIVE BREAST CARCINOMA 40 0.0969
27 POLYCHROMASIA 29 0.0967
28 METASTASES TO SPINAL CORD 18 0.0928
29 METASTASES TO THE MEDIASTINUM 36 0.0874
30 PYELITIS 18 0.0865
31 POSITRON EMISSION TOMOGRAM ABNORMAL 59 0.0844
32 BREAST INFLAMMATION 25 0.0812
33 BREAST CANCER RECURRENT 245 0.0775
34 CARCINOEMBRYONIC ANTIGEN INCREASED 150 0.0774
35 BONE LESION 278 0.0770
36 METASTASES TO BONE MARROW 37 0.0740
37 TUMOUR MARKER INCREASED 350 0.0729
38 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 90 0.0722
39 METASTASES TO SKIN 72 0.0697
40 VERTEBRAL LESION 34 0.0663
41 METASTASES TO LIVER 1150 0.0654
42 METASTASES TO LUNG 749 0.0648
43 METASTASES TO CHEST WALL 22 0.0634
44 METASTASIS 451 0.0631
45 VITILIGO 145 0.0618
46 PLEURAL THICKENING 42 0.0614
47 BASOPHIL COUNT INCREASED 46 0.0607
48 INVASIVE LOBULAR BREAST CARCINOMA 30 0.0585
49 INTESTINAL METASTASIS 21 0.0579
50 LYMPHOCYTE PERCENTAGE INCREASED 23 0.0568
51 MEAN CELL HAEMOGLOBIN INCREASED 93 0.0561
52 METASTASES TO STOMACH 22 0.0561
53 OSTEOSCLEROSIS 87 0.0552
54 MACROCYTOSIS 63 0.0543
55 BLOOD ALBUMIN ABNORMAL 28 0.0537
56 MONOCYTE COUNT DECREASED 61 0.0500
57 METASTASES TO LYMPH NODES 337 0.0499
58 HEPATIC MASS 84 0.0436
59 ASPARTATE AMINOTRANSFERASE ABNORMAL 64 0.0420
60 MEAN CELL VOLUME INCREASED 107 0.0417
61 DISCOURAGEMENT 97 0.0415
62 HEPATIC LESION 179 0.0414
63 OSTEOLYSIS 83 0.0406
64 MEAN CELL VOLUME ABNORMAL 19 0.0403
65 BLOOD UREA ABNORMAL 36 0.0383
66 PLEURAL DISORDER 24 0.0382
67 SKIN HYPOPIGMENTATION 65 0.0367
68 CATARRH 33 0.0365
69 NEUTROPHIL COUNT ABNORMAL 103 0.0364
70 HYDROTHORAX 30 0.0361
71 ALANINE AMINOTRANSFERASE DECREASED 26 0.0359
72 QRS AXIS ABNORMAL 27 0.0351
73 ALANINE AMINOTRANSFERASE ABNORMAL 74 0.0351
74 PULPITIS DENTAL 33 0.0350
75 LYMPHOCYTE COUNT ABNORMAL 39 0.0346
76 METASTASES TO KIDNEY 19 0.0345
77 HEPATOTOXICITY 757 0.0340
78 HYPERMETABOLISM 18 0.0340
79 ELECTROCARDIOGRAM QT PROLONGED 1210 0.0336
80 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 20 0.0332
81 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 18 0.0323
82 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 25 0.0321
83 RED CELL DISTRIBUTION WIDTH INCREASED 133 0.0320
84 NEUTROPENIA 4342 0.0319
85 BREAST MASS 208 0.0309
86 REFLUX GASTRITIS 37 0.0307
87 LEUKOPENIA 1520 0.0304
88 HEPATOBILIARY DISEASE 19 0.0304
89 TUMOUR PAIN 40 0.0303
90 BLOOD BILIRUBIN ABNORMAL 38 0.0297
91 RESORPTION BONE INCREASED 24 0.0293
92 METASTASES TO PERITONEUM 73 0.0289
93 LIVER FUNCTION TEST INCREASED 612 0.0285
94 INVASIVE DUCTAL BREAST CARCINOMA 77 0.0283
95 MALIGNANT NEOPLASM PROGRESSION 2842 0.0277
96 BONE CANCER 118 0.0271
97 BLOOD ALKALINE PHOSPHATASE ABNORMAL 23 0.0256
98 SPINAL PAIN 296 0.0252
99 BREAST NEOPLASM 26 0.0252
100 RED BLOOD CELL COUNT ABNORMAL 37 0.0252
101 AXILLARY MASS 26 0.0250
102 LYMPHANGIOSIS CARCINOMATOSA 26 0.0250
103 CONCOMITANT DISEASE AGGRAVATED 152 0.0246
104 BREAST DISORDER 49 0.0240
105 LYMPHOEDEMA 164 0.0237
106 SECOND PRIMARY MALIGNANCY 194 0.0233
107 NEUTROPHIL COUNT DECREASED 943 0.0231
108 SPINAL CORD NEOPLASM 20 0.0229
109 SKIN DEPIGMENTATION 31 0.0227
110 AXILLARY PAIN 33 0.0222
111 FEBRILE INFECTION 26 0.0221
112 POLYNEUROPATHY 263 0.0219
113 METASTASES TO CENTRAL NERVOUS SYSTEM 283 0.0219
114 WHITE BLOOD CELL DISORDER 57 0.0213
115 HEPATIC CYTOLYSIS 270 0.0212
116 ERYSIPELAS 106 0.0211
117 CALCIUM DEFICIENCY 27 0.0208
118 BLOOD CREATININE ABNORMAL 70 0.0202
119 CANCER PAIN 51 0.0199
120 RADIATION INJURY 21 0.0197
121 MALIGNANT PLEURAL EFFUSION 33 0.0195
122 HAEMATOCRIT ABNORMAL 24 0.0195
123 SKIN TOXICITY 110 0.0194
124 HILAR LYMPHADENOPATHY 17 0.0193
125 GENE MUTATION 38 0.0192
126 PULMONARY PAIN 56 0.0192
127 WHITE BLOOD CELL COUNT DECREASED 2076 0.0191
128 RADIATION SKIN INJURY 22 0.0190
129 NEOPLASM 218 0.0189
130 BLOOD SODIUM ABNORMAL 20 0.0188
131 WHITE BLOOD CELL COUNT ABNORMAL 120 0.0188
132 LYMPHADENOPATHY MEDIASTINAL 36 0.0188
133 HAEMATOTOXICITY 177 0.0186
134 ONYCHOCLASIS 128 0.0186
135 GAMMA-GLUTAMYLTRANSFERASE INCREASED 412 0.0186
136 BONE NEOPLASM 20 0.0186
137 PIGMENTATION DISORDER 113 0.0183
138 BLOOD CALCIUM ABNORMAL 30 0.0180
139 MOUTH INJURY 27 0.0178
140 HAEMOGLOBIN ABNORMAL 114 0.0177
141 BILIRUBIN CONJUGATED INCREASED 41 0.0175
142 TRANSAMINASES INCREASED 387 0.0174
143 BREAST PAIN 185 0.0173
144 ASPARTATE AMINOTRANSFERASE INCREASED 920 0.0173
145 HEPATIC CYST 57 0.0168
146 PRODUCT SUPPLY ISSUE 118 0.0165
147 FOOD AVERSION 28 0.0165
148 SINUS ARRHYTHMIA 21 0.0161
149 PLATELET COUNT ABNORMAL 97 0.0160
150 ALANINE AMINOTRANSFERASE INCREASED 979 0.0159
151 VULVOVAGINAL DRYNESS 51 0.0158
152 DENGUE FEVER 36 0.0157
153 PULMONARY MASS 233 0.0156
154 ELECTROCARDIOGRAM ABNORMAL 121 0.0154
155 ELECTROCARDIOGRAM T WAVE ABNORMAL 24 0.0154
156 FRACTURED SACRUM 19 0.0153
157 BREAST CANCER STAGE IV 43 0.0151
158 RED BLOOD CELL COUNT DECREASED 433 0.0151
159 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 25 0.0150
160 SKIN HYPERTROPHY 42 0.0149
161 BICYTOPENIA 29 0.0148
162 LYMPHOCYTE COUNT INCREASED 48 0.0147
163 EOSINOPHIL COUNT DECREASED 35 0.0147
164 GLOMERULAR FILTRATION RATE DECREASED 180 0.0146
165 LAZINESS 25 0.0146
166 BREAST DISCHARGE 25 0.0143
167 BILE DUCT STENOSIS 17 0.0142
168 BONE PAIN 830 0.0142
169 APHTHOUS ULCER 108 0.0139
170 MUCOSAL DRYNESS 28 0.0139
171 MONOCYTE COUNT INCREASED 50 0.0138
172 BLOOD ALKALINE PHOSPHATASE INCREASED 341 0.0137
173 NAIL DISORDER 120 0.0137
174 HYPERTRANSAMINASAEMIA 94 0.0135
175 HEPATIC NEOPLASM 44 0.0135
176 GLOMERULAR FILTRATION RATE ABNORMAL 19 0.0134
177 MUSCULOSKELETAL CHEST PAIN 207 0.0134
178 METASTASES TO MENINGES 30 0.0132
179 GRANULOCYTE COUNT DECREASED 24 0.0129
180 PERIODONTITIS 28 0.0129
181 HEPATIC PAIN 55 0.0129
182 EATING DISORDER 274 0.0129
183 SPINAL CORD INJURY 22 0.0126
184 VEIN RUPTURE 21 0.0125
185 THERAPY PARTIAL RESPONDER 195 0.0125
186 SENSITIVE SKIN 90 0.0122
187 MYOPIA 29 0.0122
188 PLEURAL EFFUSION 741 0.0122
189 BLOOD THYROID STIMULATING HORMONE ABNORMAL 22 0.0119
190 BREAST SWELLING 32 0.0119
191 ASTIGMATISM 18 0.0119
192 INVESTIGATION ABNORMAL 17 0.0118
193 IMMUNODEFICIENCY 176 0.0118
194 NODULE 154 0.0118
195 PRODUCT TEMPERATURE EXCURSION ISSUE 60 0.0117
196 BLOOD POTASSIUM ABNORMAL 31 0.0116
197 FULL BLOOD COUNT ABNORMAL 123 0.0116
198 EYE ALLERGY 18 0.0116
199 BONE MARROW DISORDER 35 0.0116
200 BLOOD BILIRUBIN INCREASED 312 0.0115
201 ASCITES 339 0.0115
202 PATHOLOGICAL FRACTURE 58 0.0114
203 BLOOD CREATININE DECREASED 35 0.0112
204 MENOPAUSAL SYMPTOMS 26 0.0112
205 INTRA-ABDOMINAL FLUID COLLECTION 20 0.0112
206 FEELING OF DESPAIR 52 0.0111
207 FEEDING DISORDER 224 0.0110
208 LYMPHOCYTE COUNT DECREASED 195 0.0110
209 SPINAL CORD DISORDER 18 0.0109
210 HAEMATOCRIT DECREASED 214 0.0108
211 BLOOD CALCIUM DECREASED 121 0.0107
212 OSTEONECROSIS OF JAW 264 0.0107
213 FULL BLOOD COUNT DECREASED 214 0.0106
214 PNEUMONITIS 289 0.0106
215 COMPUTERISED TOMOGRAM ABNORMAL 24 0.0106
216 CELL DEATH 21 0.0106
217 BLOOD CREATININE INCREASED 689 0.0105
218 SPINAL COLUMN INJURY 23 0.0103
219 YELLOW SKIN 48 0.0102
220 CONCOMITANT DISEASE PROGRESSION 20 0.0102
221 OROPHARYNGEAL DISCOMFORT 92 0.0102
222 VOCAL CORD PARALYSIS 18 0.0100
223 HEPATIC ENZYME ABNORMAL 49 0.0098
224 HEPATIC NECROSIS 37 0.0098
225 TASTE DISORDER 199 0.0098
226 CORONAVIRUS INFECTION 64 0.0097
227 STENOSIS 18 0.0096
228 DYSCHEZIA 29 0.0095
229 HEPATITIS 242 0.0094
230 BREAST CANCER 876 0.0094
231 RECURRENT CANCER 38 0.0093
232 SPINAL CORD COMPRESSION 36 0.0092
233 NECK MASS 26 0.0092
234 BLOOD TEST ABNORMAL 129 0.0092
235 HEPATIC ENZYME INCREASED 625 0.0092
236 DYSENTERY 17 0.0091
237 THYROID MASS 35 0.0091
238 LUNG OPACITY 24 0.0091
239 SKIN INJURY 30 0.0090
240 GENERAL PHYSICAL HEALTH DETERIORATION 1039 0.0090
241 GASTRITIS 234 0.0089
242 SKIN ATROPHY 51 0.0089
243 HEPATOMEGALY 87 0.0088
244 FOOD INTOLERANCE 32 0.0087
245 PLATELET DISORDER 22 0.0087
246 HERPES VIRUS INFECTION 50 0.0087
247 SKIN WRINKLING 23 0.0085
248 BLOOD LACTATE DEHYDROGENASE INCREASED 134 0.0084
249 SYNOVIAL CYST 39 0.0084
250 HYDRONEPHROSIS 63 0.0084
251 VEIN DISORDER 42 0.0084
252 SUPRAVENTRICULAR EXTRASYSTOLES 28 0.0083
253 MYELOSUPPRESSION 298 0.0083
254 LYMPHADENITIS 20 0.0083
255 TRICHORRHEXIS 23 0.0082
256 BONE DISORDER 150 0.0082
257 CHEST INJURY 17 0.0082
258 CARBOHYDRATE ANTIGEN 125 INCREASED 28 0.0082
259 BLOOD PHOSPHORUS DECREASED 30 0.0082
260 GLOSSITIS 29 0.0082
261 ANAEMIA 1557 0.0082
262 SPINAL DISORDER 77 0.0081
263 METASTATIC NEOPLASM 35 0.0081
264 GRANULOCYTOPENIA 46 0.0081
265 HEPATITIS TOXIC 21 0.0081
266 LIVER DISORDER 356 0.0080
267 HAEMOGLOBIN DECREASED 822 0.0080
268 ODYNOPHAGIA 47 0.0079
269 LABORATORY TEST ABNORMAL 231 0.0078
270 GENERAL PHYSICAL CONDITION ABNORMAL 53 0.0078
271 RHINITIS 63 0.0078
272 FEMORAL NECK FRACTURE 40 0.0078
273 HYPERTENSIVE CRISIS 86 0.0077
274 LYMPHADENOPATHY 272 0.0077
275 NASAL DRYNESS 48 0.0077
276 MOVEMENT DISORDER 245 0.0076
277 LACRIMATION INCREASED 230 0.0076
278 ALOPECIA 1490 0.0076
279 BLOOD CHOLESTEROL ABNORMAL 35 0.0076
280 INTERNATIONAL NORMALISED RATIO ABNORMAL 26 0.0076
281 BLOOD CALCIUM INCREASED 66 0.0075
282 THROMBOCYTOPENIA 834 0.0075
283 AORTIC ARTERIOSCLEROSIS 19 0.0074
284 GOITRE 30 0.0073
285 RENAL FUNCTION TEST ABNORMAL 34 0.0073
286 ORGAN FAILURE 29 0.0072
287 NECROSIS 40 0.0072
288 CYTOPENIA 87 0.0071
289 MUCOSAL INFLAMMATION 186 0.0071
290 BLOOD URIC ACID INCREASED 41 0.0071
291 LIVER INJURY 174 0.0071
292 HOT FLUSH 533 0.0071
293 HEPATIC FAILURE 213 0.0071
294 TRICUSPID VALVE INCOMPETENCE 56 0.0070
295 HAEMOGLOBIN INCREASED 32 0.0070
296 PLATELET COUNT DECREASED 745 0.0070
297 TOOTHACHE 126 0.0070
298 BILIARY COLIC 20 0.0069
299 PERIPHERAL SENSORY NEUROPATHY 40 0.0068
300 TONGUE ULCERATION 23 0.0068
301 OESOPHAGEAL CANDIDIASIS 27 0.0068
302 HYPOCALCAEMIA 128 0.0068
303 SLUGGISHNESS 68 0.0067
304 VITAMIN D DEFICIENCY 65 0.0067
305 PRODUCT AVAILABILITY ISSUE 151 0.0066
306 ASPHYXIA 54 0.0066
307 CACHEXIA 34 0.0066
308 HEAD DISCOMFORT 116 0.0065
309 BLOOD CREATINE INCREASED 29 0.0065
310 JAUNDICE 176 0.0065
311 AGEUSIA 163 0.0065
312 RED BLOOD CELL COUNT INCREASED 18 0.0065
313 RECTAL CANCER 20 0.0065
314 GASTROINTESTINAL INFECTION 58 0.0065
315 MADAROSIS 75 0.0065
316 HEPATIC STEATOSIS 119 0.0064
317 HYPERBILIRUBINAEMIA 66 0.0064
318 MASS 89 0.0064
319 NAIL DISCOLOURATION 25 0.0064
320 AUTOIMMUNE HEPATITIS 44 0.0063
321 DYSSTASIA 184 0.0063
322 PULMONARY OEDEMA 282 0.0063
323 DECREASED APPETITE 1446 0.0062
324 HUMERUS FRACTURE 30 0.0062
325 DYSPNOEA AT REST 18 0.0062
326 JAW DISORDER 34 0.0062
327 DEPRESSED MOOD 328 0.0062
328 TRIGGER FINGER 25 0.0061
329 BLOOD UREA INCREASED 102 0.0061
330 DRUG-INDUCED LIVER INJURY 191 0.0061
331 ANAL HAEMORRHAGE 17 0.0061
332 PELVIC PAIN 110 0.0060
333 DRUG TOLERANCE DECREASED 17 0.0060
334 IRON DEFICIENCY 27 0.0060
335 OCULAR ICTERUS 26 0.0060
336 OVERWEIGHT 32 0.0060
337 HORMONE LEVEL ABNORMAL 29 0.0059
338 LYMPHOPENIA 84 0.0059
339 ILLNESS 610 0.0059
340 HYPOALBUMINAEMIA 46 0.0059
341 TENSION 36 0.0059
342 SECRETION DISCHARGE 74 0.0059
343 PLATELET COUNT INCREASED 77 0.0059
344 LIVER FUNCTION TEST ABNORMAL 170 0.0058
345 RHINITIS ALLERGIC 26 0.0058
346 MITRAL VALVE INCOMPETENCE 66 0.0058
347 VARICOSE VEIN 30 0.0058
348 PHARYNGITIS 72 0.0058
349 DISCOMFORT 348 0.0057
350 SCRATCH 60 0.0057
351 DYSPNOEA EXERTIONAL 214 0.0057
352 BLOOD ALBUMIN DECREASED 45 0.0057
353 TONGUE DISCOMFORT 24 0.0056
354 SPINAL FRACTURE 113 0.0056
355 SKIN DISCOLOURATION 258 0.0056
356 LEFT VENTRICULAR HYPERTROPHY 24 0.0056
357 WOUND 156 0.0056
358 GROIN PAIN 49 0.0056
359 MUSCULOSKELETAL DISCOMFORT 96 0.0056
360 INFLAMMATION 286 0.0055
361 BREAST ENLARGEMENT 18 0.0055
362 LIMB DISCOMFORT 170 0.0055
363 CHROMATURIA 124 0.0055
364 DISEASE PROGRESSION 649 0.0055
365 CLAVICLE FRACTURE 21 0.0055
366 LUMBAR VERTEBRAL FRACTURE 25 0.0055
367 FLANK PAIN 51 0.0054
368 GINGIVAL SWELLING 24 0.0054
369 SKIN LESION 149 0.0054
370 ARRHYTHMIA 257 0.0054
371 BUNDLE BRANCH BLOCK LEFT 23 0.0054
372 CONSTIPATION 1178 0.0054
373 FOREIGN BODY IN THROAT 17 0.0054
374 PELVIC FRACTURE 42 0.0054
375 PRODUCT DISTRIBUTION ISSUE 50 0.0054
376 NEOPLASM MALIGNANT 359 0.0054
377 APHONIA 75 0.0054
378 TONSILLITIS 28 0.0054
379 FIBRIN D DIMER INCREASED 19 0.0053
380 RENAL IMPAIRMENT 449 0.0053
381 DERMATITIS ALLERGIC 67 0.0053
382 SKIN REACTION 75 0.0053
383 NEOPLASM RECURRENCE 18 0.0053
384 DRUG INTOLERANCE 510 0.0053
385 HYPERCALCAEMIA 65 0.0053
386 HYPOVENTILATION 17 0.0052
387 HAIR GROWTH ABNORMAL 36 0.0052
388 AORTIC VALVE INCOMPETENCE 22 0.0052
389 HYPOKINESIA 75 0.0052
390 DRY SKIN 688 0.0051
391 HYPOVOLAEMIA 30 0.0051
392 CHOKING 100 0.0051
393 FATIGUE 3986 0.0051
394 BRAIN NEOPLASM 47 0.0051
395 SINUS BRADYCARDIA 49 0.0051
396 RETCHING 107 0.0050
397 C-REACTIVE PROTEIN INCREASED 182 0.0050
398 METABOLIC DISORDER 29 0.0050
399 SENSORY LOSS 40 0.0050
400 NAUSEA 3932 0.0050
401 DRY THROAT 50 0.0049
402 GINGIVAL PAIN 39 0.0049
403 BLOOD DISORDER 39 0.0049
404 EPIGASTRIC DISCOMFORT 19 0.0049
405 CYSTITIS 153 0.0048
406 THROAT CLEARING 18 0.0048
407 NEOPLASM PROGRESSION 167 0.0048
408 SKIN MASS 32 0.0048
409 GASTROINTESTINAL TOXICITY 23 0.0048
410 PAROSMIA 36 0.0048
411 HEPATITIS ACUTE 31 0.0048
412 SKIN DISORDER 159 0.0048
413 ONYCHOMADESIS 20 0.0048
414 BACK PAIN 1106 0.0048
415 COUGH 1329 0.0047
416 PERFORMANCE STATUS DECREASED 22 0.0047
417 UMBILICAL HERNIA 22 0.0047
418 VOMITING 2210 0.0047
419 PHLEBITIS 24 0.0047
420 DYSPEPSIA 461 0.0047
421 INFARCTION 32 0.0047
422 BLOOD THYROID STIMULATING HORMONE INCREASED 43 0.0047
423 CENTRAL NERVOUS SYSTEM LESION 64 0.0047
424 ORAL DISORDER 34 0.0046
425 DYSPHAGIA 440 0.0046
426 BLOOD MAGNESIUM DECREASED 40 0.0046
427 FAECES HARD 18 0.0046
428 LIP DRY 42 0.0046
429 URINE ABNORMALITY 21 0.0046
430 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20 0.0046
431 BRAIN FOG 72 0.0046
432 HAEMORRHOIDS 89 0.0046
433 VULVOVAGINAL DISCOMFORT 20 0.0045
434 LUNG DISORDER 219 0.0045
435 ASTHENIA 1680 0.0045
436 INFLUENZA 498 0.0045
437 GAIT INABILITY 149 0.0045
438 PURULENT DISCHARGE 19 0.0044
439 FEELING OF BODY TEMPERATURE CHANGE 26 0.0044
440 VENTRICULAR EXTRASYSTOLES 46 0.0044
441 GINGIVAL DISORDER 17 0.0044
442 MUSCLE ATROPHY 56 0.0044
443 RENAL CYST 35 0.0044
444 PANCYTOPENIA 244 0.0044
445 DIVERTICULUM INTESTINAL 19 0.0043
446 RENAL PAIN 46 0.0043
447 PERIPHERAL SWELLING 666 0.0043
448 RED BLOOD CELL SEDIMENTATION RATE INCREASED 47 0.0042
449 SKIN FISSURES 83 0.0042
450 ORAL PAIN 95 0.0042
451 ORGANISING PNEUMONIA 21 0.0042
452 SKIN EXFOLIATION 356 0.0042
453 INTERVERTEBRAL DISC DISORDER 18 0.0042
454 DRY EYE 210 0.0042
455 ILL-DEFINED DISORDER 254 0.0042
456 PERIPHERAL VENOUS DISEASE 17 0.0042
457 SLEEP DISORDER 293 0.0041
458 HYPERTHYROIDISM 60 0.0041
459 BUNDLE BRANCH BLOCK RIGHT 19 0.0041
460 STOMATITIS 251 0.0041
461 ISCHAEMIA 19 0.0041
462 RALES 24 0.0041
463 ABDOMINAL DISCOMFORT 688 0.0041
464 HIATUS HERNIA 53 0.0041
465 FEAR 110 0.0041
466 EYE INFLAMMATION 39 0.0041
467 IMMUNOSUPPRESSION 36 0.0041
468 BLOOD PRESSURE ABNORMAL 81 0.0041
469 LIGAMENT SPRAIN 40 0.0040
470 CHOLECYSTITIS 48 0.0040
471 PERICARDIAL EFFUSION 93 0.0040
472 PAIN IN EXTREMITY 1183 0.0040
473 SCIATICA 64 0.0040
474 PRODUCT PACKAGING ISSUE 38 0.0040
475 TOXIC SKIN ERUPTION 40 0.0040
476 SKELETAL INJURY 41 0.0040
477 IMMUNE SYSTEM DISORDER 52 0.0039
478 SARS-COV-2 TEST POSITIVE 52 0.0039
479 VIRAL INFECTION 131 0.0039
480 PRODUCTIVE COUGH 187 0.0039
481 FEELING COLD 109 0.0039
482 PNEUMOTHORAX 62 0.0039
483 OVARIAN CANCER 36 0.0039
484 CARDIOMEGALY 48 0.0039
485 ENDOCARDITIS 20 0.0039
486 VITAMIN D DECREASED 33 0.0039
487 OESOPHAGITIS 42 0.0038
488 SWELLING OF EYELID 24 0.0038
489 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 89 0.0038
490 DERMATITIS 80 0.0038
491 NEUTROPHIL COUNT INCREASED 39 0.0038
492 PYELONEPHRITIS 33 0.0038
493 CHOKING SENSATION 21 0.0038
494 MALAISE 1670 0.0038
495 THERMAL BURN 27 0.0038
496 CHOLESTASIS 73 0.0038
497 LIPASE INCREASED 29 0.0038
498 HAEMATOMA 98 0.0038
499 RASH MACULAR 132 0.0038
500 THERAPY CHANGE 37 0.0038
501 MALNUTRITION 42 0.0038
502 URINE ODOUR ABNORMAL 22 0.0037
503 LUNG INFILTRATION 33 0.0037
504 HYPERGLYCAEMIA 136 0.0037
505 TOOTH FRACTURE 41 0.0037
506 PRURITUS 1426 0.0037
507 DENTAL CARIES 41 0.0037
508 HYPOKALAEMIA 171 0.0037
509 CEREBRAL ISCHAEMIA 19 0.0037
510 OSTEOPENIA 56 0.0037
511 MOUTH SWELLING 21 0.0036
512 MEMORY IMPAIRMENT 498 0.0036
513 APPETITE DISORDER 24 0.0036
514 SKIN HYPERPIGMENTATION 31 0.0036
515 GINGIVAL BLEEDING 49 0.0036
516 CARDIOTOXICITY 32 0.0036
517 VISUAL IMPAIRMENT 443 0.0036
518 ATRIAL FIBRILLATION 348 0.0036
519 ARTHRALGIA 1485 0.0036
520 BLOOD SODIUM DECREASED 67 0.0036
521 PULMONARY FIBROSIS 68 0.0035
522 WEIGHT DECREASED 989 0.0035
523 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 636 0.0035
524 BLOOD PRESSURE DIASTOLIC DECREASED 26 0.0035
525 HYPOPHOSPHATAEMIA 26 0.0035
526 RASH VESICULAR 17 0.0035
527 PYREXIA 1214 0.0035
528 NEUTROPENIC SEPSIS 25 0.0035
529 OROPHARYNGEAL PAIN 324 0.0035
530 ABDOMINAL PAIN UPPER 718 0.0035
531 PHOTOPSIA 22 0.0035
532 FRUSTRATION TOLERANCE DECREASED 28 0.0035
533 HEPATIC CIRRHOSIS 65 0.0035
534 ULCER 55 0.0035
535 OEDEMA PERIPHERAL 421 0.0035
536 PRODUCT USE COMPLAINT 54 0.0034
537 DYSPHONIA 200 0.0034
538 SPEECH DISORDER 178 0.0034
539 CHOLELITHIASIS 111 0.0034
540 BLOOD PRESSURE SYSTOLIC INCREASED 66 0.0034
541 HYPOPHAGIA 86 0.0034
542 THROMBOSIS 270 0.0034
543 OSTEOARTHRITIS 141 0.0033
544 HEPATOCELLULAR INJURY 47 0.0033
545 SKIN LACERATION 36 0.0033
546 NASOPHARYNGITIS 610 0.0033
547 LACTIC ACIDOSIS 107 0.0033
548 DIARRHOEA 2125 0.0033
549 HAIR TEXTURE ABNORMAL 44 0.0033
550 URINARY TRACT INFECTION 561 0.0033
551 MULTIPLE ORGAN DYSFUNCTION SYNDROME 93 0.0033
552 MOUTH ULCERATION 69 0.0033
553 GASTROINTESTINAL PAIN 36 0.0033
554 GAIT DISTURBANCE 623 0.0033
555 COVID-19 571 0.0033
556 DRY MOUTH 264 0.0033
557 SCAB 37 0.0032
558 SENSORY DISTURBANCE 52 0.0032
559 DRUG RESISTANCE 83 0.0032
560 RASH PRURITIC 173 0.0032
561 HYPERSENSITIVITY 592 0.0032
562 SPINAL OSTEOARTHRITIS 28 0.0032
563 OSTEOPOROSIS 131 0.0032
564 FOOD POISONING 17 0.0032
565 ANAL FISSURE 17 0.0032
566 SINUS TACHYCARDIA 45 0.0032
567 FAECES SOFT 23 0.0032
568 PAIN 1940 0.0032
569 TERMINAL STATE 21 0.0031
570 NERVOUSNESS 163 0.0031
571 INTERSTITIAL LUNG DISEASE 151 0.0031
572 RIB FRACTURE 64 0.0031
573 ATELECTASIS 30 0.0031
574 ARTHROPOD BITE 23 0.0031
575 BLISTER 174 0.0031
576 INCREASED APPETITE 59 0.0031
577 RASH 1343 0.0031
578 ACUTE HEPATIC FAILURE 42 0.0031
579 TOOTH DISORDER 68 0.0031
580 DIABETES MELLITUS 232 0.0030
581 INTERVERTEBRAL DISC PROTRUSION 66 0.0030
582 APATHY 44 0.0030
583 EPISTAXIS 225 0.0030
584 RENAL DISORDER 140 0.0030
585 GENERALISED OEDEMA 37 0.0030
586 CEREBRAL DISORDER 22 0.0030
587 FEMUR FRACTURE 92 0.0030
588 DEATH 2554 0.0030
589 TOOTH INFECTION 39 0.0030
590 DERMATITIS ACNEIFORM 18 0.0030
591 RENAL FAILURE 392 0.0029
592 PULMONARY EMBOLISM 280 0.0029
593 CRYING 107 0.0029
594 TACHYCARDIA 261 0.0029
595 BLOOD POTASSIUM DECREASED 88 0.0029
596 UROSEPSIS 27 0.0029
597 BLOOD GLUCOSE ABNORMAL 54 0.0029
598 DYSPNOEA 1652 0.0029
599 ACUTE RESPIRATORY FAILURE 56 0.0029
600 FRACTURE 55 0.0029
601 MOBILITY DECREASED 208 0.0029
602 HYPOTHYROIDISM 92 0.0029
603 DYSURIA 106 0.0029
604 NERVE INJURY 32 0.0029
605 CHILLS 337 0.0029
606 EXTRASYSTOLES 20 0.0029
607 PLEURISY 17 0.0029
608 ABDOMINAL DISTENSION 297 0.0028
609 ANOSMIA 41 0.0028
610 FEELING ABNORMAL 674 0.0028
611 GASTROINTESTINAL INFLAMMATION 22 0.0028
612 SCAR 48 0.0028
613 AFFECTIVE DISORDER 22 0.0028
614 JOINT STIFFNESS 73 0.0028
615 DIARRHOEA HAEMORRHAGIC 26 0.0028
616 SWELLING 259 0.0028
617 CARDIAC FAILURE 222 0.0028
618 DERMATITIS BULLOUS 20 0.0028
619 NEPHROPATHY TOXIC 31 0.0028
620 URINARY RETENTION 92 0.0028
621 VERTIGO 168 0.0028
622 CONJUNCTIVITIS 51 0.0027
623 HYPERTENSION 581 0.0027
624 PNEUMONIA BACTERIAL 25 0.0027
625 POISONING 34 0.0027
626 SALIVARY HYPERSECRETION 27 0.0027
627 HYPERCHOLESTEROLAEMIA 26 0.0027
628 COLITIS 102 0.0027
629 PALLOR 73 0.0027
630 ABDOMINAL PAIN 624 0.0027
631 PAIN OF SKIN 72 0.0027
632 NECK PAIN 149 0.0027
633 THYROID DISORDER 41 0.0027
634 ARTERIOSCLEROSIS 25 0.0027
635 HEMIPLEGIA 22 0.0026
636 SYNCOPE 264 0.0026
637 ABSCESS 42 0.0026
638 BURNING SENSATION 184 0.0026
639 SUPRAVENTRICULAR TACHYCARDIA 25 0.0026
640 JOINT EFFUSION 18 0.0026
641 DEHYDRATION 348 0.0026
642 DIZZINESS 1301 0.0026
643 BLOOD TRIGLYCERIDES INCREASED 46 0.0026
644 FLUID RETENTION 132 0.0026
645 THROAT IRRITATION 116 0.0026
646 EYE DISORDER 85 0.0026
647 OCULAR DISCOMFORT 29 0.0026
648 PULMONARY CONGESTION 34 0.0026
649 LIMB INJURY 70 0.0026
650 RHINORRHOEA 166 0.0026
651 HYPERKALAEMIA 90 0.0026
652 ORAL HERPES 50 0.0026
653 JOINT DISLOCATION 27 0.0026
654 KIDNEY INFECTION 50 0.0025
655 HEPATIC FUNCTION ABNORMAL 95 0.0025
656 OEDEMA 138 0.0025
657 PHOTOSENSITIVITY REACTION 42 0.0025
658 HEAD INJURY 80 0.0025
659 EAR PAIN 49 0.0025
660 DIPLOPIA 65 0.0025
661 TONGUE DISORDER 18 0.0025
662 FLATULENCE 141 0.0025
663 GASTROINTESTINAL DISORDER 222 0.0025
664 BRONCHITIS 183 0.0025
665 PRODUCT STORAGE ERROR 216 0.0025
666 ERYTHEMA MULTIFORME 23 0.0025
667 UTERINE LEIOMYOMA 18 0.0025
668 DECUBITUS ULCER 20 0.0025
669 MOOD SWINGS 78 0.0024
670 ABNORMAL FAECES 20 0.0024
671 DYSGEUSIA 181 0.0024
672 RESPIRATORY DISORDER 72 0.0024
673 PAIN IN JAW 68 0.0024
674 ERYTHEMA 492 0.0024
675 JOINT INJURY 51 0.0024
676 NEURALGIA 58 0.0024
677 DIVERTICULITIS 66 0.0024
678 PALPITATIONS 278 0.0024
679 INSOMNIA 632 0.0024
680 EMOTIONAL DISORDER 73 0.0024
681 CHEST PAIN 437 0.0024
682 FACIAL PAIN 21 0.0024
683 ACUTE KIDNEY INJURY 359 0.0023
684 WHITE BLOOD CELL COUNT INCREASED 90 0.0023
685 CYST 29 0.0023
686 HELICOBACTER INFECTION 24 0.0023
687 FEELING HOT 143 0.0023
688 PARALYSIS 33 0.0023
689 CATARACT 137 0.0023
690 THIRST 41 0.0023
691 PNEUMONIA 741 0.0023
692 BLOOD POTASSIUM INCREASED 37 0.0023
693 FAECES DISCOLOURED 49 0.0023
694 INFECTION 327 0.0023
695 UPPER GASTROINTESTINAL HAEMORRHAGE 38 0.0023
696 ATRIAL FLUTTER 18 0.0023
697 BODY TEMPERATURE INCREASED 46 0.0023
698 IMPAIRED HEALING 74 0.0023
699 HEADACHE 1412 0.0022
700 BODY HEIGHT DECREASED 24 0.0022
701 MOOD ALTERED 61 0.0022
702 SNEEZING 50 0.0022
703 FACIAL PARALYSIS 19 0.0022
704 GASTROOESOPHAGEAL REFLUX DISEASE 179 0.0022
705 COAGULOPATHY 37 0.0022
706 FOOD ALLERGY 17 0.0022
707 COVID-19 PNEUMONIA 26 0.0022
708 ATRIOVENTRICULAR BLOCK 17 0.0022
709 HYPERAESTHESIA 18 0.0022
710 GLAUCOMA 42 0.0022
711 MUSCULOSKELETAL PAIN 114 0.0022
712 HERPES ZOSTER 125 0.0022
713 SUDDEN DEATH 23 0.0022
714 EYE PRURITUS 73 0.0022
715 SKIN ULCER 56 0.0022
716 TOOTH ABSCESS 22 0.0022
717 ORAL DISCOMFORT 30 0.0022
718 HUNGER 30 0.0022
719 CARPAL TUNNEL SYNDROME 30 0.0021
720 RESPIRATORY RATE INCREASED 19 0.0021
721 BRAIN OEDEMA 27 0.0021
722 ABDOMINAL PAIN LOWER 54 0.0021
723 SKIN PLAQUE 18 0.0021
724 DECREASED ACTIVITY 23 0.0021
725 CANDIDA INFECTION 36 0.0021
726 PULMONARY THROMBOSIS 23 0.0021
727 SOMNOLENCE 423 0.0021
728 ASPIRATION 23 0.0021
729 OSTEOMYELITIS 38 0.0021
730 HAEMATEMESIS 53 0.0021
731 WRIST FRACTURE 25 0.0021
732 MUSCLE STRAIN 18 0.0021
733 RESTLESSNESS 76 0.0021
734 OBESITY 33 0.0021
735 EYE SWELLING 77 0.0021
736 MYALGIA 350 0.0021
737 GASTROENTERITIS 30 0.0021
738 NEUROPATHY PERIPHERAL 195 0.0020
739 POLLAKIURIA 85 0.0020
740 BLOOD CHOLESTEROL INCREASED 95 0.0020
741 BACTERIAL INFECTION 38 0.0020
742 TEMPERATURE INTOLERANCE 21 0.0020
743 UPPER RESPIRATORY TRACT INFECTION 94 0.0020
744 SKIN HAEMORRHAGE 30 0.0020
745 HYPERSOMNIA 58 0.0020
746 HYPOACUSIS 87 0.0020
747 MICTURITION URGENCY 23 0.0020
748 PRODUCT DOSE OMISSION IN ERROR 57 0.0020
749 ILEUS 25 0.0020
750 HYPOAESTHESIA 301 0.0020
751 GLOSSODYNIA 45 0.0020
752 WOUND INFECTION 22 0.0020
753 ANAL INCONTINENCE 18 0.0020
754 THERAPY INTERRUPTED 143 0.0020
755 POOR QUALITY SLEEP 43 0.0020
756 FEBRILE NEUTROPENIA 132 0.0020
757 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 34 0.0020
758 PRODUCT PRESCRIBING ERROR 47 0.0020
759 ERUCTATION 38 0.0020
760 UPPER LIMB FRACTURE 39 0.0020
761 FACE OEDEMA 33 0.0020
762 PHARYNGEAL SWELLING 19 0.0019
763 BLOOD IRON DECREASED 23 0.0019
764 RASH MACULO-PAPULAR 43 0.0019
765 VITREOUS FLOATERS 19 0.0019
766 RESPIRATORY TRACT INFECTION 50 0.0019
767 ORAL CANDIDIASIS 25 0.0019
768 ELECTROLYTE IMBALANCE 22 0.0019
769 BRONCHOSPASM 27 0.0019
770 APHASIA 57 0.0019
771 PROCEDURAL PAIN 52 0.0019
772 AFFECT LABILITY 18 0.0019
773 HIP FRACTURE 60 0.0019
774 CELLULITIS 94 0.0019
775 RESPIRATORY FAILURE 135 0.0018
776 DEEP VEIN THROMBOSIS 120 0.0018
777 MYOCARDIAL ISCHAEMIA 21 0.0018
778 DEAFNESS 48 0.0018
779 EPILEPSY 56 0.0018
780 HYPERHIDROSIS 236 0.0018
781 THERAPY CESSATION 94 0.0018
782 DEMENTIA 51 0.0018
783 PETECHIAE 19 0.0018
784 NOCTURIA 22 0.0018
785 HYPONATRAEMIA 101 0.0018
786 VISION BLURRED 246 0.0018
787 DEPRESSION 407 0.0018
788 CARDIAC DISORDER 167 0.0018
789 SKIN INFECTION 20 0.0018
790 LOWER LIMB FRACTURE 34 0.0018
791 ANXIETY 502 0.0018
792 LOWER RESPIRATORY TRACT INFECTION 80 0.0018
793 DRUG ERUPTION 31 0.0017
794 CHEST DISCOMFORT 179 0.0017
795 PARAESTHESIA 275 0.0017
796 PERIPHERAL COLDNESS 24 0.0017
797 ANGINA PECTORIS 50 0.0017
798 MUSCLE SPASMS 319 0.0017
799 DRUG INTERACTION 275 0.0017
800 SKIN IRRITATION 79 0.0017
801 HEPATIC CANCER 41 0.0017
802 ACUTE MYOCARDIAL INFARCTION 50 0.0017
803 BLINDNESS 69 0.0017
804 WEIGHT INCREASED 379 0.0017
805 SWELLING FACE 110 0.0017
806 BLOOD PRESSURE INCREASED 258 0.0017
807 LETHARGY 97 0.0017
808 BLOOD URINE PRESENT 32 0.0017
809 FALL 561 0.0017
810 GASTRIC ULCER 32 0.0017
811 TENDONITIS 26 0.0017
812 ACCIDENT 20 0.0017
813 EJECTION FRACTION DECREASED 26 0.0017
814 CONTUSION 161 0.0017
815 HYPOGLYCAEMIA 81 0.0017
816 BRADYCARDIA 88 0.0017
817 CONFUSIONAL STATE 265 0.0016
818 FOOT FRACTURE 31 0.0016
819 TREMOR 270 0.0016
820 DEVICE RELATED INFECTION 25 0.0016
821 MUSCULAR WEAKNESS 181 0.0016
822 DISORIENTATION 63 0.0016
823 CIRCULATORY COLLAPSE 27 0.0016
824 HEART RATE INCREASED 157 0.0016
825 OSTEONECROSIS 52 0.0016
826 MUSCULOSKELETAL STIFFNESS 138 0.0016
827 MENTAL DISORDER 68 0.0016
828 OXYGEN SATURATION DECREASED 87 0.0015
829 RASH ERYTHEMATOUS 74 0.0015
830 HAEMATOCHEZIA 85 0.0015
831 BLOOD COUNT ABNORMAL 23 0.0015
832 BACTERAEMIA 18 0.0015
833 QUALITY OF LIFE DECREASED 20 0.0015
834 MUSCLE TIGHTNESS 24 0.0015
835 ACUTE MYELOID LEUKAEMIA 23 0.0015
836 AMNESIA 96 0.0015
837 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
838 HEART RATE IRREGULAR 33 0.0015
839 INFLUENZA LIKE ILLNESS 120 0.0015
840 NEPHROLITHIASIS 66 0.0014
841 HAEMOPTYSIS 40 0.0014
842 IRRITABILITY 86 0.0014
843 RESTLESS LEGS SYNDROME 26 0.0014
844 NASAL CONGESTION 83 0.0014
845 NIGHT SWEATS 45 0.0014
846 RHABDOMYOLYSIS 58 0.0014
847 DISTURBANCE IN ATTENTION 75 0.0014
848 DRUG LEVEL INCREASED 23 0.0014
849 GASTROENTERITIS VIRAL 25 0.0014
850 BLOOD GLUCOSE INCREASED 259 0.0014
851 BLOOD PRESSURE DECREASED 91 0.0014
852 LUNG NEOPLASM MALIGNANT 56 0.0014
853 SEPSIS 151 0.0014
854 BREAST CANCER FEMALE 36 0.0013
855 OFF LABEL USE 1178 0.0013
856 CARDIO-RESPIRATORY ARREST 56 0.0013
857 HYPOAESTHESIA ORAL 20 0.0013
858 URINARY INCONTINENCE 39 0.0013
859 CEREBROVASCULAR ACCIDENT 222 0.0013
860 TYPE 2 DIABETES MELLITUS 44 0.0013
861 JOINT SWELLING 157 0.0013
862 HAEMORRHAGE 135 0.0013
863 BALANCE DISORDER 111 0.0013
864 LOCALISED INFECTION 31 0.0013
865 MENINGIOMA 20 0.0013
866 BONE MARROW FAILURE 26 0.0013
867 SKIN BURNING SENSATION 91 0.0013
868 HYPOTENSION 253 0.0013
869 TOOTH LOSS 26 0.0013
870 RASH PAPULAR 28 0.0012
871 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 65 0.0012
872 RECTAL HAEMORRHAGE 53 0.0012
873 ISCHAEMIC STROKE 22 0.0012
874 AGITATION 90 0.0012
875 PHOTOPHOBIA 23 0.0012
876 COGNITIVE DISORDER 57 0.0012
877 TINNITUS 56 0.0012
878 COORDINATION ABNORMAL 17 0.0012
879 URTICARIA 204 0.0012
880 VAGINAL HAEMORRHAGE 52 0.0012
881 BONE LOSS 18 0.0012
882 THERAPY NON-RESPONDER 53 0.0012
883 PRODUCT DOSE OMISSION ISSUE 345 0.0012
884 CHRONIC KIDNEY DISEASE 89 0.0012
885 BLOOD PRESSURE FLUCTUATION 28 0.0012
886 HYPOXIA 41 0.0012
887 CORONARY ARTERY DISEASE 35 0.0012
888 MIGRAINE 110 0.0012
889 EYE PAIN 65 0.0012
890 CARDIOMYOPATHY 17 0.0011
891 LOSS OF CONSCIOUSNESS 147 0.0011
892 DRUG EFFECT LESS THAN EXPECTED 17 0.0011
893 ADVERSE DRUG REACTION 103 0.0011
894 THROAT TIGHTNESS 31 0.0011
895 TOXICITY TO VARIOUS AGENTS 192 0.0011
896 HERNIA 22 0.0011
897 CARDIAC ARREST 93 0.0011
898 HEMIPARESIS 19 0.0011
899 DISEASE RECURRENCE 53 0.0011
900 INJURY 78 0.0011
901 GLYCOSYLATED HAEMOGLOBIN INCREASED 28 0.0011
902 SEPTIC SHOCK 48 0.0011
903 CARDIOVASCULAR DISORDER 28 0.0011
904 PRODUCT USE ISSUE 206 0.0011
905 SINUSITIS 112 0.0011
906 AMENORRHOEA 19 0.0011
907 EYE IRRITATION 62 0.0011
908 PRESYNCOPE 26 0.0011
909 ARTHRITIS 84 0.0011
910 OCULAR HYPERAEMIA 50 0.0011
911 GASTRIC DISORDER 36 0.0010
912 ACNE 79 0.0010
913 POST PROCEDURAL COMPLICATION 20 0.0010
914 BLOOD GLUCOSE DECREASED 50 0.0010
915 DELIRIUM 36 0.0010
916 GALLBLADDER DISORDER 18 0.0010
917 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
918 PRODUCT USE IN UNAPPROVED INDICATION 249 0.0010
919 MELAENA 22 0.0010
920 HEART RATE DECREASED 35 0.0010
921 LEUKOCYTOSIS 18 0.0010
922 NERVOUS SYSTEM DISORDER 31 0.0010
923 FUNGAL INFECTION 33 0.0010
924 INTESTINAL OBSTRUCTION 37 0.0010
925 ANGER 33 0.0010
926 SKIN CANCER 21 0.0010
927 INCORRECT DOSE ADMINISTERED 216 0.0009
928 DYSARTHRIA 35 0.0009
929 SEIZURE 107 0.0009
930 AGRANULOCYTOSIS 17 0.0009
931 INTENTIONAL DOSE OMISSION 26 0.0009
932 CEREBRAL INFARCTION 22 0.0009
933 STEVENS-JOHNSON SYNDROME 20 0.0009
934 ARTHROPATHY 50 0.0009
935 DRUG INEFFECTIVE 1183 0.0009
936 FREQUENT BOWEL MOVEMENTS 24 0.0009
937 LIP SWELLING 29 0.0009
938 SHOCK 20 0.0009
939 MYOCARDIAL INFARCTION 150 0.0009
940 MENSTRUATION IRREGULAR 23 0.0009
941 THERAPEUTIC RESPONSE DECREASED 52 0.0009
942 PANIC ATTACK 31 0.0008
943 IRRITABLE BOWEL SYNDROME 18 0.0008
944 MENTAL IMPAIRMENT 20 0.0008
945 CONDITION AGGRAVATED 248 0.0008
946 METABOLIC ACIDOSIS 26 0.0008
947 RENAL INJURY 24 0.0008
948 HALLUCINATION, VISUAL 17 0.0008
949 PNEUMONIA ASPIRATION 20 0.0008
950 RESPIRATORY DISTRESS 22 0.0008
951 PRODUCT PRESCRIBING ISSUE 17 0.0008
952 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
953 ECZEMA 40 0.0008
954 MUSCLE TWITCHING 17 0.0007
955 EXPIRED PRODUCT ADMINISTERED 24 0.0007
956 DIABETIC KETOACIDOSIS 17 0.0007
957 PANCREATITIS 37 0.0007
958 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 18 0.0007
959 CARDIAC FAILURE CONGESTIVE 56 0.0007
960 MENTAL STATUS CHANGES 18 0.0006
961 DYSKINESIA 24 0.0006
962 WHEEZING 35 0.0006
963 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
964 TREATMENT FAILURE 47 0.0006
965 SURGERY 32 0.0005
966 CEREBRAL HAEMORRHAGE 19 0.0005
967 UNEVALUABLE EVENT 40 0.0005
968 ROAD TRAFFIC ACCIDENT 22 0.0005
969 EMOTIONAL DISTRESS 62 0.0005
970 ANAPHYLACTIC REACTION 28 0.0005
971 MEDICATION ERROR 28 0.0005
972 ANGIOEDEMA 22 0.0005
973 HALLUCINATION 37 0.0005
974 ASTHMA 55 0.0005
975 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
976 FLUSHING 47 0.0005
977 INJECTION SITE MASS 17 0.0005
978 ABNORMAL BEHAVIOUR 18 0.0005
979 COMA 21 0.0004
980 UNDERDOSE 28 0.0004
981 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
982 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 65 0.0003
983 HOSPITALISATION 42 0.0003
984 SUICIDAL IDEATION 25 0.0003
985 PSORIASIS 33 0.0003
986 INJECTION SITE PAIN 76 0.0002
987 RHEUMATOID ARTHRITIS 26 0.0002
988 INTENTIONAL PRODUCT USE ISSUE 19 0.0002
989 ADVERSE EVENT 18 0.0002
990 OVERDOSE 35 0.0002
991 NO ADVERSE EVENT 27 0.0001